Entia Biosciences Inc ERGO
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.03 / $0.05
- Shares Outstanding
- 33.66M
- Market Cap
- $77,420.18
- Volume/Avg
- 5,000 / 3,628
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. The company is also engaged in the discovery, scientific evaluation and marketing of natural formulations used in medical foods, nutraceuticals, cosmetics and other related products. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 7
- Website
- —
Valuation
Metric | ERGO |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | ERGO |
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.11 |
Interest Coverage | −15.71 |
Quick Ratio
ERGO
Profitability
Metric | ERGO |
|---|---|
Return on Assets (Normalized) | −278.64% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ERGO
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|L<y<nt | LOCK|?Pyf | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|P@Db@Q | LOCK|tjkN | $95B | |||
| Moderna Inc MRNA | LOCK|^><F@n | LOCK|>b | $79B | |||
| argenx SE ADR ARGX | LOCK|LC#qm^l | LOCK|?% | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|<>C?tZ | LOCK|H<@ | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|RmBdtZv | LOCK|%V&Nl | $30B | |||
| Incyte Corp INCY | LOCK|k!WSB^t | LOCK|&& | $23B | |||
| BioNTech SE ADR BNTX | LOCK|%!Dm%p | LOCK|d^ | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|%R>kkK? | LOCK|X#Yb | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|W<^z^K^ | LOCK|%q | $15B |